Table 4

Results of the transplantation of CD34CD38, CD34CD38+, CD34+CD38+, and CD34+CD38 fractions from AML

AML sampleSubtypeStrainTime, weeksCD34CD38
CD34CD38+
CD34+CD38+
CD34+CD38
Mice with AML/mice transplanted (mean percentage of AML)Mice with AML/mice transplanted (mean percentage of AML)Mice with AML/mice transplanted (mean percentage of AML)Mice with AML/mice transplanted (mean percentage of AML)
B2m 12 NT* NT* NT* 0/2 
NSG 12-14 2/2 (99%) 3/3 (49%) 0/1 0/2 
B2m 5-9 0/2 3/3 (70%) NT§ NT§ 
9i NSG 17 2/2 (53%) 1/1 (84%) 0/1 Died 
9ii B2m 12-15 1/2 (0.1%) 1/1 (0.3%) NT 0/1 
10 NSG 16 1/1 (0.3%) 2/2 (26%) 0/1 0/1 
12 NSG 16 0/2 2/2 (0.3%) 0/1 0/3 
15 NSG 8-15 0/1 1/3 (2.5%) 4/5 (1.4%) 0/3 
17i B2m 9-12 6/6 (57%) 7/8 (39%) 6/8 (32%) 4/6 (38%) 
17ii NSG 12 NT NT NT 1/2 (76%) 
18 B2m 10 0/1 1/1 (4.4%) 1/1 (3.7%) 1/1 (1.6%) 
19 B2m 12 0/2 1/2 (0.1%) 0/2 1/2 (0.3%) 
24 B2m 12 1/1 (20%) 2/2 (40%) 2/2 (11%) (24%) 
25 B2m 12 0/2 3/3 (6.7%) 3/3 (26%) 0/1 
26 B2m 12 3/3 (73.3%) 3/3 (37.2%) 1/1 (8.9%) 1/1 (0.9%) 
WT2 NA B2m 4/4 (49%) 0/1 0/1 NA 
AML sampleSubtypeStrainTime, weeksCD34CD38
CD34CD38+
CD34+CD38+
CD34+CD38
Mice with AML/mice transplanted (mean percentage of AML)Mice with AML/mice transplanted (mean percentage of AML)Mice with AML/mice transplanted (mean percentage of AML)Mice with AML/mice transplanted (mean percentage of AML)
B2m 12 NT* NT* NT* 0/2 
NSG 12-14 2/2 (99%) 3/3 (49%) 0/1 0/2 
B2m 5-9 0/2 3/3 (70%) NT§ NT§ 
9i NSG 17 2/2 (53%) 1/1 (84%) 0/1 Died 
9ii B2m 12-15 1/2 (0.1%) 1/1 (0.3%) NT 0/1 
10 NSG 16 1/1 (0.3%) 2/2 (26%) 0/1 0/1 
12 NSG 16 0/2 2/2 (0.3%) 0/1 0/3 
15 NSG 8-15 0/1 1/3 (2.5%) 4/5 (1.4%) 0/3 
17i B2m 9-12 6/6 (57%) 7/8 (39%) 6/8 (32%) 4/6 (38%) 
17ii NSG 12 NT NT NT 1/2 (76%) 
18 B2m 10 0/1 1/1 (4.4%) 1/1 (3.7%) 1/1 (1.6%) 
19 B2m 12 0/2 1/2 (0.1%) 0/2 1/2 (0.3%) 
24 B2m 12 1/1 (20%) 2/2 (40%) 2/2 (11%) (24%) 
25 B2m 12 0/2 3/3 (6.7%) 3/3 (26%) 0/1 
26 B2m 12 3/3 (73.3%) 3/3 (37.2%) 1/1 (8.9%) 1/1 (0.9%) 
WT2 NA B2m 4/4 (49%) 0/1 0/1 NA 

The AML sample is indicated in the first column and the subtype in the second. Some samples were tested in more than one strain of mouse (indicated by the lowercase Roman numeral). NSG indicates that NOD/SCID/IL2rγ−/− mice were used in the experiment; B2m, NOD/SCID/β2m−/− mice; NT, not tested; WT2, wild-type NPM AML sample 2; and NA, not applicable as this sample lacks a CD34+CD38 population. The figures in parentheses indicate the mean percentage of AML in the mouse bone marrow.

*

The LICs from sample 1 are restricted to the CD34 fraction (Table 3).

Normal multilineage engraftment observed from the CD34+CD38 fraction from one or more mice. The DNA from the grafts contained wild-type NPM.

The graft was assessed by quantitative PCR and shown to contain mutated NPM.

§

LICs are not found in the CD34dim and CD34+ fractions that include all the CD34+CD38+ and CD34+CD38 cells (Table 3).

Both CD45+CD33+ and CD45+CD19+ populations were observed in some mice transplanted with CD34+CD38 cells. The CD19+ cells contain mostly wild-type NPM, whereas the CD33+ fractions contain mostly mutant NPM, consistent with the presence of LICs and normal repopulating cells in the CD34+CD38 fraction. Some of the data from the CD34+CD38+ and CD34+CD38 fractions of samples 15 and 18 have been previously published.3

or Create an Account

Close Modal
Close Modal